• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists.

作者信息

Ferrario Alessandra, Orubu Ebiowei Samuel F, Adeyeye Moji Christianah, Zaman Muhammad H, Wirtz Veronika J

机构信息

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, United States of America.

Institute for Health System Innovation and Policy, Boston University, Boston, Massachusetts, United States of America.

出版信息

BMJ Glob Health. 2019 Jul 18;4(4):e001681. doi: 10.1136/bmjgh-2019-001681. eCollection 2019.

DOI:10.1136/bmjgh-2019-001681
PMID:31406593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6666819/
Abstract
摘要

相似文献

1
The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists.药剂师针对不合格和伪造药品进行全面多学科培训的必要性。
BMJ Glob Health. 2019 Jul 18;4(4):e001681. doi: 10.1136/bmjgh-2019-001681. eCollection 2019.
2
Fighting trafficking of falsified and substandard medicinal products in Russia.打击俄罗斯假药和劣药的非法交易。
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.
3
Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.非洲和亚洲的地方组织使用低成本的全球公共卫生实验室微量实验室对假药和劣药进行监测。
PLoS One. 2017 Sep 6;12(9):e0184165. doi: 10.1371/journal.pone.0184165. eCollection 2017.
4
Prevalence of substandard and falsified artemisinin-based combination antimalarial medicines on Bioko Island, Equatorial Guinea.赤道几内亚比奥科岛不合格及伪造的青蒿素类复方抗疟药品的流行情况。
BMJ Glob Health. 2017 Oct 15;2(4):e000409. doi: 10.1136/bmjgh-2017-000409. eCollection 2017.
5
Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.埃塞俄比亚的药品监管框架：对其法律基础与实施情况的批判性评估
Ethiop J Health Sci. 2016 May;26(3):259-76. doi: 10.4314/ejhs.v26i3.9.
6
When falsified medicines enter the supply chain: description of an incident in Kenya and lessons learned for rapid response.当假药进入供应链时：肯尼亚事件描述及快速应对的经验教训。
J Public Health Policy. 2013 Jan;34(1):22-30. doi: 10.1057/jphp.2012.53. Epub 2012 Nov 22.
7
Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.防范假药的公共卫生干预措施：对国际、国家和地方政策的系统评价
Health Policy Plan. 2016 Dec;31(10):1448-1466. doi: 10.1093/heapol/czw062. Epub 2016 Jun 16.
8
Legal aspects of counteracting the trafficking of falsified medicines in the european union.欧盟打击假药 trafficking 的法律方面。（原句中“trafficking”后似乎少了关键内容，比如“trafficking in”之类，导致“假药trafficking”表述不太完整准确）
Wiad Lek. 2017;70(4):843-849.
9
Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions.观点：假药与劣药：不同的问题需要不同的解决办法。
J Public Health Policy. 2015 Nov;36(4):384-9. doi: 10.1057/jphp.2015.22. Epub 2015 Jul 16.
10
The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists.波兰的《欧洲假药指令》：背景、实施情况及对药剂师的潜在建议。
Eur J Hosp Pharm. 2018 Jan;25(1):10-15. doi: 10.1136/ejhpharm-2016-000970. Epub 2016 Jul 27.

引用本文的文献

1
The challenges associated with the prevention of smuggling and counterfeiting health goods in Iran.伊朗在预防走私和假冒伪劣卫生用品方面面临的挑战。
BMC Public Health. 2024 Jun 11;24(1):1564. doi: 10.1186/s12889-024-18637-0.
2
Exploring pharmacists' perspectives about substandard and falsified medical products through interviews.通过访谈探索药剂师对不合格和假冒医疗产品的看法。
Explor Res Clin Soc Pharm. 2024 Feb 14;13:100421. doi: 10.1016/j.rcsop.2024.100421. eCollection 2024 Mar.
3
Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs.重新审视劣质和假药作为低收入和中等收入国家抗菌药物耐药性驱动因素的盲点。
Ann Med Surg (Lond). 2023 Feb 7;85(2):122-123. doi: 10.1097/MS9.0000000000000113. eCollection 2023 Feb.
4
Improved knowledge on substandard and falsified (SF) medical products through a dedicated course for pharmacy students at three universities in sub-Saharan Africa.通过在撒哈拉以南非洲的三所大学为药学学生开设专门课程，提高了对劣药和假药（SF）的认识。
BMJ Glob Health. 2023 Feb;6(Suppl 3). doi: 10.1136/bmjgh-2022-009367.
5
A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives.关于网上不合标准和伪造药品可得性的批判性综述：发生率、挑战与展望。
J Med Access. 2022 Feb 15;6:23992026221074548. doi: 10.1177/23992026221074548. eCollection 2022 Jan-Dec.
6
Evaluation of pharmacists' awareness of illegal online pharmacies and perceived impact on safe access to medicines.药剂师对非法网上药店的认知及对药品安全获取的感知影响评估。
Med Access Point Care. 2021 Apr 18;5:23992026211005642. doi: 10.1177/23992026211005642. eCollection 2021 Jan-Dec.
7
Small-scale dissolution test screening tool to select potentially substandard and falsified (SF) medicines requiring full pharmacopoeial analysis.用于筛选可能不合格和伪造（SF）药品的小规模溶解试验筛选工具，这些药品需要进行全面的药典分析。
Sci Rep. 2021 Jun 9;11(1):12145. doi: 10.1038/s41598-021-91443-5.
8
Negative Consequences of the Widespread and Inappropriate Easy Access to Purchasing Prescription Medications on the Internet.在互联网上广泛且不适当地容易获取处方药进行购买的负面后果。
Am Health Drug Benefits. 2021 Mar;14(1):22-28.
9
The Need for Ongoing Antimicrobial Stewardship during the COVID-19 Pandemic and Actionable Recommendations.新冠疫情期间持续开展抗菌药物管理的必要性及可行建议
Antibiotics (Basel). 2020 Dec 14;9(12):904. doi: 10.3390/antibiotics9120904.

本文引用的文献

1
Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania.识别不合格和假药的市场风险：基于中国、印度尼西亚、土耳其和罗马尼亚定性研究的分析框架。
Wellcome Open Res. 2019 Apr 16;4:70. doi: 10.12688/wellcomeopenres.15236.1. eCollection 2019.
2
Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.中低收入国家不合格和假冒药品的流行情况及经济负担估计：系统评价和荟萃分析。
JAMA Netw Open. 2018 Aug 3;1(4):e181662. doi: 10.1001/jamanetworkopen.2018.1662.
3
A challenge for healthcare but just another opportunity for illegitimate online sellers: Dubious market of shortage oncology drugs.对医疗保健来说是一个挑战，但对非法在线卖家来说只是另一个机会：短缺肿瘤药物的可疑市场。
PLoS One. 2018 Aug 28;13(8):e0203185. doi: 10.1371/journal.pone.0203185. eCollection 2018.
4
Fake medicines: fighting on all fronts.假药：全面出击对抗。
Lancet Respir Med. 2018 May;6(5):315. doi: 10.1016/S2213-2600(18)30152-8. Epub 2018 Apr 10.
5
Oncology drugs in the crosshairs of pharmaceutical crime.肿瘤药物成为制药犯罪的目标。
Lancet Oncol. 2018 Apr;19(4):e209-e217. doi: 10.1016/S1470-2045(18)30101-3.
6
Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy.在低收入和中等收入国家打击劣质药品：宣传与教育的重要性。
J Pharm Policy Pract. 2016 Nov 10;9:36. doi: 10.1186/s40545-016-0088-0. eCollection 2016.
7
Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.防范假药的公共卫生干预措施：对国际、国家和地方政策的系统评价
Health Policy Plan. 2016 Dec;31(10):1448-1466. doi: 10.1093/heapol/czw062. Epub 2016 Jun 16.
8
Substandard/counterfeit antimicrobial drugs.不合格/假冒抗菌药物。
Clin Microbiol Rev. 2015 Apr;28(2):443-64. doi: 10.1128/CMR.00072-14.
9
Mind the gaps--the epidemiology of poor-quality anti-malarials in the malarious world--analysis of the WorldWide Antimalarial Resistance Network database.关注差距——疟疾流行地区劣质抗疟药物的流行病学——对全球抗疟药物耐药性网络数据库的分析
Malar J. 2014 Apr 8;13:139. doi: 10.1186/1475-2875-13-139.